tirzepatide effect on kidneys Renal effects of GLP-1 receptor agonists and in individuals with type 2 diabetes: seeds of a promising future | Endocrine Not currently a kidney therapy.

One of the cases was thought to be related to semaglutide use, whereas the other was suspected to be unrelated because of a coinciding food-borne illness and pump malfunction

Your provider can also rule out other causes, such as bacterial overgrowth (SIBO) or gallbladder issues, which occasionally emerge during rapid weight loss

(PubMed) Mah E, Pei R, Guo Y, et al

Clinical trials (SURPASS and SURMOUNT programmes) have shown that dual agonists may offer improved glycaemic control and weight reduction compared to GLP-1 monotherapy

After lipopolysaccharide/ Brucella abortus administration, the treatment of mice with olive extract (400 mg/kg p.o.) for 19 days significantly decreased immobility time and hyperalgesia along with an attenuation of oxidative stress (brain lipid peroxidation, reduced glutathione (GSH) levels, brain nitrite levels) and serum TNF- levels

Experimental data by Fork, et al